Neogenomics (NEO) PT Raised to $16 at Benchmark
Tweet
Share
E-mailGet Alerts NEO Hot Sheet
Price: $17.56 --0%
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 59
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 59
Join SI Premium – FREE
Benchmark analyst Bruce Jackson raised the price target on Neogenomics (NASDAQ: NEO) to $16.00 (from $11.00) while maintaining a Buy rating.
You May Also Be Interested In
- The Children's Place (PLCE) PT Lowered to $3.25 at UBS on Soft Sales Trends
- 'Chime Financial (CHYM) to Acquire Stride Bank'; PT Raised to $38 at BMO Capital
- SLB (SLB) PT Raised to $72 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
